AP NEWS

The Monoclonal Antibodies Market - Global Forecasts to 2023 - ResearchAndMarkets.com

September 11, 2018

DUBLIN--(BUSINESS WIRE)--Sep 11, 2018--The “Monoclonal Antibodies Market - Forecasts from 2018 to 2023” report has been added to ResearchAndMarkets.com’s offering.

The monoclonal antibodies market is projected to grow at a CAGR of 6.34% to reach US$131.766 billion by 2023, from US$91.122 billion in 2017.

The market for monoclonal antibodies is driven by persistent innovation in drug development and discovery, increasing incidences of chronic diseases, favorable regulatory policies, and high adoption rate of therapeutic antibodies in emerging economies.

Key Topics Covered

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics

5. Monoclonal Antibodies Market by Indication

6. Monoclonal Antibodies Market by Source

7. Monoclonal Antibodies Market by Application

8. Monoclonal Antibodies Market by End-User

9. Monoclonal Antibodies Market by Geography

10. Competitive Intelligence

11. Company Profiles

Eli Lily and Company AbbVie, Inc. Novartis AG Bristol Myers Squibb F.Hoffmann-La Roche Ltd. Johnson & Johnson Services, Inc. Amgen Inc. Merck & Co. Inc. Abbott AstraZeneca PLC

For more information about this report visit https://www.researchandmarkets.com/research/bjwq2r/the_monoclonal?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180911005595/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Immune Disorders Drugs,Biopharmaceuticals

KEYWORD:

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/11/2018 11:43 AM/DISC: 09/11/2018 11:43 AM

http://www.businesswire.com/news/home/20180911005595/en

AP RADIO
Update hourly